Company / Profit Margin
LEXICON PHARMACEUTICALS, INC. Profit Margin History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-14710.9%
FY2025
5-year range
-73341.0% / -165.9%
FY2021-FY2025
Trend
+79.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin returned to growth in FY2025 after 4 years of decline, reaching -14710.9%.
Based on SEC 10-K filings.
-14710.9% in FY2025 with a 10-year CAGR of -10024.7%.
Improved from -29449.0% to -14710.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -10024.7pp
Key checks
Key Insights
- In FY2025, profit margin increased 79.9% year-over-year.
- Peak profit margin was recorded in FY2017.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14710.9% | +79.9% |
| FY2024 | -73341.0% | -149.0% |
| FY2023 | -29449.0% | -11963.8% |
| FY2019 | -244.1% | -47.2% |
| FY2018 | -165.9% | -4506.9% |
| FY2017 | -3.6% | +99.2% |
| FY2016 | -438.8% | +90.6% |
| FY2015 | -4686.1% | +53.7% |
| FY2014 | -10120.4% | -61.0% |
| FY2013 | -6285.3% | -203.1% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026